0.00
price down icon100.00%   -0.0322
after-market Handel nachbörslich: .03 0.03 +
loading
Schlusskurs vom Vortag:
$0.0322
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.80M
Einnahmen:
$1.33M
Nettoeinkommen (Verlust:
$-138.49M
KGV:
0.00
EPS:
-1.2
Netto-Cashflow:
$-126.22M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$2.94

Gritstone Bio Inc Stock (GRTS) Company Profile

Name
Firmenname
Gritstone Bio Inc
Name
Telefon
(510) 871-6100
Name
Adresse
5959 HORTON STREET, SUITE 300, EMERYVILLE, CA
Name
Mitarbeiter
231
Name
Twitter
@gritstoneonc
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
GRTS's Discussions on Twitter

Vergleichen Sie GRTS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GRTS
Gritstone Bio Inc
0.00 3.80M 1.33M -138.49M -126.22M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
488.34 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
718.16 78.51B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
580.43 35.27B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
238.74 30.91B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.71 26.37B 3.32B -860.46M -1.04B -8.32

Gritstone Bio Inc Stock (GRTS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-03-31 Eingeleitet Evercore ISI Outperform
2023-03-28 Eingeleitet B. Riley Securities Buy
2022-10-31 Eingeleitet Piper Sandler Overweight
2022-08-22 Herabstufung Goldman Neutral → Sell
2021-12-15 Fortgesetzt Goldman Neutral
2021-10-15 Fortgesetzt BTIG Research Buy
2021-01-20 Herabstufung Robert W. Baird Outperform → Underperform
2019-07-26 Eingeleitet Robert W. Baird Outperform
2019-03-15 Eingeleitet Raymond James Outperform
2019-03-07 Eingeleitet H.C. Wainwright Buy
2018-10-23 Eingeleitet BTIG Research Buy
2018-10-23 Eingeleitet Goldman Neutral
Alle ansehen

Gritstone Bio Inc Aktie (GRTS) Neueste Nachrichten

pulisher
Mar 10, 2025

Investors who lost money on Gritstone bio, Inc.(GRTS) should contact Levi & Korsinsky about pending Class ActionGRTS - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 03, 2025

Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Levi & Korsinsky Reminds Gritstone bio, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 6, 2024GRTS - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

GRTS DEADLINE ALERT: Bernstein Liebhard LLP Reminds Gritstone bio, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 6, 2024 in Gritstone LawsuitGRTS - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 28, 2025

GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Delisting of Securities of Adamas One Corp.; Hempacco Co., Inc.; Iris Acquisition Corp; Aura FAT Projects Acquisition Corp.; Newbury Street Acquisition Corporation; Arogo Capital Acquisition Corp.; Compass Digital Acquisition Corp.; Gritstone bio, Inc.; Notabl - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

10 Companies Purged From Nasdaq: What Happened to These Suspended Stocks? - StockTitan

Feb 27, 2025
pulisher
Feb 26, 2025

Shareholders of Gritstone bio, Inc. Should Contact Levi & Korsinsky Before August 6, 2024 to Discuss Your RightsGRTS - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 26, 2025

Gritstone bio files monthly operating report amid Chapter 11 By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 25, 2025

Gritstone bio Files for Chapter 11 Bankruptcy - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

Gritstone bio files monthly operating report amid Chapter 11 - Investing.com

Feb 25, 2025
pulisher
Feb 20, 2025

FINAL GRTS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 20, 2025

GRTS SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 20, 2025
pulisher
Feb 19, 2025

GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Gritstone bio, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 19, 2025
pulisher
Feb 13, 2025

Investigation announced for Long-Term Investors in Gritstone bio, Inc. (NASDAQ: GRTS) over potential Wrongdoing - openPR

Feb 13, 2025
pulisher
Feb 12, 2025

Cancer Vaccines Therapeutics Market Size Report 2032 | - openPR

Feb 12, 2025
pulisher
Feb 03, 2025

GRITSTONE BIO, INC. (NASDAQ: GRTS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Gritstone bio, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Feb 03, 2025
pulisher
Jan 24, 2025

Gritstone (GRTS) Plummets 58% in a Week: Here's Why - MSN

Jan 24, 2025
pulisher
Jan 06, 2025

Gritstone bio completes asset sale amid bankruptcy - Investing.com India

Jan 06, 2025
pulisher
Jan 06, 2025

Gritstone bio completes asset sale amid bankruptcy By Investing.com - Investing.com Australia

Jan 06, 2025
pulisher
Jan 06, 2025

Seattle Project Corp agreed to acquire Substantially all of the assets of Gritstone bio, Inc. from Gritstone bio, Inc. (OTCPK:GRTS.Q) for $21.2 million. - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

Seattle Project Corp completed the acquisition of Substantially all of the assets of Gritstone bio, Inc. from Gritstone bio, Inc. (OTCPK:GRTS.Q). - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

Leader of failed biotech urges others to hire colleagues - The Business Journals

Jan 06, 2025
pulisher
Jan 04, 2025

Gritstone Bio, Inc. Announces Resignation of Executives - Marketscreener.com

Jan 04, 2025
pulisher
Jan 04, 2025

Gritstone Bio, Inc. Announces CEO Changes - Marketscreener.com

Jan 04, 2025
pulisher
Jan 03, 2025

Gritstone bio Completes Asset Sale Amid Bankruptcy - TipRanks

Jan 03, 2025
pulisher
Jan 02, 2025

GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com

Jan 02, 2025
pulisher
Dec 21, 2024

Gritstone bio CFO sells $180 in common stock - Investing.com India

Dec 21, 2024
pulisher
Dec 21, 2024

Gritstone bio CFO sells $180 in common stock By Investing.com - Investing.com Australia

Dec 21, 2024
pulisher
Dec 16, 2024

Gritstone bio assets auctioned for $21.25 million By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 15, 2024

Gritstone bio assets auctioned for $21.25 million - Investing.com

Dec 15, 2024
pulisher
Dec 13, 2024

Gritstone Bio sets sale of assets through Bankruptcy Court - The Business Journals

Dec 13, 2024
pulisher
Dec 13, 2024

Gritstone Bio Files for Bankruptcy and Auctions Assets - TipRanks

Dec 13, 2024
pulisher
Dec 01, 2024

B. Riley Securities Downgrades Gritstone bio (GRTS) - MSN

Dec 01, 2024
pulisher
Nov 30, 2024

Gritstone bio reports October financials amid Chapter 11 - Investing.com India

Nov 30, 2024
pulisher
Nov 30, 2024

Gritstone bio reports October financials amid Chapter 11 By Investing.com - Investing.com South Africa

Nov 30, 2024
pulisher
Nov 25, 2024

Gritstone bio (GRTSQ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - MSN

Nov 25, 2024
pulisher
Nov 19, 2024

Bidding Procedure Approved for Gritstone bio, Inc. - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Final DIP Financing Approved for Gritstone bio, Inc. - Marketscreener.com

Nov 19, 2024
pulisher
Nov 15, 2024

Gritstone bio : Bankruptcy Form 8 K - Marketscreener.com

Nov 15, 2024

Finanzdaten der Gritstone Bio Inc-Aktie (GRTS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.49
price down icon 2.14%
$18.50
price up icon 2.83%
$304.42
price down icon 4.23%
$32.46
price down icon 0.89%
$98.39
price down icon 6.61%
biotechnology ONC
$245.71
price up icon 1.26%
Kapitalisierung:     |  Volumen (24h):